Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali
Clinical trial NCT06624943 · COMPLETED
Trial details
- NCT number
- NCT06624943
- Sponsor
- Life for a Child Program, Diabetes Australia
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2023-05-05
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.